MediWound
MediWound
Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.
About
Technology stack
detected 2026-06-26No comments yet. Be the first to share your take.
What does MediWound do?
MediWound develops and commercializes next-generation enzymatic therapeutics for non-surgical tissue repair, focusing on selective eschar removal for burns and chronic wounds. Their core products, NexoBrid® and EscharEx®, aim to accelerate healing, improve outcomes, and lower healthcare costs for patients worldwide. The company is a fully integrated biotechnology firm with approved products and a strong pipeline addressing significant unmet medical needs.
How much funding has MediWound raised?
MediWound has raised a total of $55M in funding. The most recent round on record is Post-IPO.
Where is MediWound headquartered?
MediWound is headquartered in Yavne, Israel.
When was MediWound founded?
MediWound was founded in 2000.
What industry does MediWound operate in?
MediWound operates in Healthcare, MedTech, HealthTech, Biotechnology, Drug Discovery, Clinical Trials.
How many employees does MediWound have?
MediWound has approximately 105 people on record.